LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea ("OSA") and insomnia, today announced that it has entered into a collaboration agreement with South Palm Cardiovascular Associates, LLC ("SPCVA"), a growing Florida-based cardiology practice with approximately 30,000 patients of record, to support the formation and operation of AIM Florida, LLC ("AIM Florida"), a physician-aligned management services organization intended to expand access to integrated diagnostic and therapeutic clinical treatment services for cardiovascular disease (“CVD”) patients in Florida who also suffer from OSA and insomnia. R. Kirk Huntsman, Chairman and Chief Executive Officer of Vivos said, "We believe this key collaboration agreement with SPCVA represents a unique and highly profitable model for creating additional such relationships across multiple medical specialties throughout the country. It is based on our current successful model that we have established as a result of our 2025 acquisition of Sleep Centers of Nevada. The key difference here is that we are partnering directly with the medical community without incurring the significant capital outlays required in an acquisition. By creating a true collaboration with fully aligned interests, all parties expect to raise the standard of care for patients who suffer from both OSA and CVD. By aligning our technology and services platform with an experienced Florida cardiology group, we believe AIM Florida can create a scalable, compliant model for expanding access to comprehensive sleep and breathing health solutions throughout the state of Florida, and eventually to the more than 2,500 similar cardiology groups throughout the country." The collaboration will address the key concerns that SPCVA cardiologists have experienced with patients who have some form of CVD along with OSA. Obstructive sleep apnea is independently associated with an increased risk of cardiovascular events and all-cause mortality, particularly among patients with moderate-to-severe disease. Moreover, SPCVA cardiologists report that obtaining timely diagnosis and treatment for these patients has been a longstanding concern, consistent with a recognized national shortage of board-certified sleep medicine specialists. Vivos expects to hold not less than 80% of the membership interests in AIM Florida, with SPCVA holding up to 20%, subject to definitive documentation and applicable regulatory requirements. SPCVA is owned by board-certified cardiologists operating a multi-location private cardiology practice in Florida. The parties intend for the collaboration to initially focus on patients in the Palm Beach County, Florida market, with the goal of helping identify, diagnose and support treatment of OSA and other sleep-disordered breathing conditions that are often associated with serious cardiometabolic and chronic health conditions. Based on its experience in Las Vegas, Vivos believes the AIM Florida model, when fully established, will contribute to the Company’s cash flow and profitability. The operating plan calls for the initial establishment of one fully staffed Sleep Optimization Team capable of serving roughly 250 patients per month and generating in excess of $6,000,000 per year with contribution margins approaching 50% once fully deployed. Additional teams can be added to meet the expected growing demand over time. SPCVA physicians have expressed a desire to assist AIM Florida in expanding to other Florida communities and among other cardiology and specialty medical practices. The Company expects that collaborations with additional physician groups and sleep healthcare providers can help broaden patient access to diagnostics and treatment while supporting Vivos' long-term commercial growth strategy. The collaboration is intended to operate in compliance with applicable federal and state healthcare laws, including the federal Anti-Kickback Statute, physician self-referral rules to the extent applicable, and Florida healthcare regulatory requirements. Under the Agreement, all clinical decisions, patient care protocols, supervision of licensed providers and referral decisions will remain exclusively within the authority of licensed healthcare professionals and will not be directed, controlled or incentivized by Vivos, AIM Florida, SPCVA or any other non-clinical party. The parties anticipate negotiating and executing definitive agreements and related ancillary documents, including management services agreements with affiliated clinical entities. Until then, there can be no assurance that the contemplated definitive agreements will be completed on the expected timeline or at all, and even if completed, that the terms therein would be construed as fa